News + Filings Transactions
|
Kosacz Barbara
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2023 | XOMA Corp | XOMA | Grant | Non-Qualified Share Option (right to buy) | 11k | $21.39 | $234.6k | | 05/17/2023 |
| 07/25/2022 | Kronos Bio, Inc. | KRON | Grant | Common Stock | 53.6k | $0.00 | $0 | | 07/25/2022 |
| 05/20/2022 | Athira Pharma, Inc. | ATHA | Grant | Stock Option (Right to Buy) | 13.9k | $8.93 | $123.9k | | 05/20/2022 |
| 05/18/2022 | XOMA Corp | XOMA | Grant | Non-Qualified Share Option (right to buy) | 9k | $17.86 | $160.7k | | 05/18/2022 |
| 02/15/2022 | Kronos Bio, Inc. | KRON | Grant | Employee Stock Option (Right to Buy) | 80k | $7.08 | $566.4k | | 02/15/2022 |
| 02/15/2022 | Kronos Bio, Inc. | KRON | Grant | Common Stock | 53.6k | $0.00 | $0 | | 02/15/2022 |
| 10/08/2021 | PHOENIX BIOTECH ACQUISITION CORP. | | Other (acquisition) | Class B Common Stock | 17.5k | $0.00 | $0 | By Phoenix Biotech Sponsor, LLC | 10/08/2021 |
| 05/19/2021 | XOMA Corp | XOMA | Grant | Non-Qualified Share Option (right to buy) | 5.1k | $31.04 | $158.3k | | 05/19/2021 |
| 03/04/2021 | Athira Pharma, Inc. | ATHA | Grant | Stock Option (Right to Buy) | 27.7k | $19.29 | $535.1k | | 03/04/2021 |
| 01/12/2021 | eFFECTOR Therapeutics, Inc. | | Other (disposition) | Class B Common Stock | 17.5k | $0.00 | $0 | By LWAC D&O LLC | 01/12/2021 |
| 12/09/2020 | Kronos Bio, Inc. | KRON | Grant | Employee Stock Option (Right to Buy) | 104.7k | $30.94 | $3.2M | | 12/09/2020 |
| 12/09/2020 | Kronos Bio, Inc. | KRON | Grant | Common Stock | 69.8k | $0.00 | $0 | | 12/09/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Purchase | Common Stock | 5.2k | $19.00 | $99.8k | | 10/14/2020 |
| 05/20/2020 | XOMA Corp | XOMA | Grant | Non-Qualified Share Option (right to buy) | 6.2k | $21.27 | $130.9k | | 05/20/2020 |
| 05/16/2019 | XOMA Corp | XOMA | Grant | Non-Qualified Share Option (right to buy) | 8.2k | $15.59 | $127.3k | | 05/16/2019 |
| 01/01/2019 | XOMA Corp | XOMA | Grant | Non-Qualified Share Option (right to buy) | 20k | $12.65 | $252.7k | | 01/01/2019 |
|